PRQR
ProQR Therapeutics N.V

4,343
Mkt Cap
$257.05M
Volume
821,441.00
52W High
$3.10
52W Low
$1.07
PE Ratio
-5.10
PRQR Fundamentals
Price
$2.33
Prev Close
$2.36
Open
$2.36
50D MA
$2.38
Beta
0.88
Avg. Volume
324,482.00
EPS (Annual)
-$0.3488
P/B
3.66
Loading...
Loading...
News
all
press releases
ProQR Therapeutics N.V. (NASDAQ:PRQR) Receives Average Recommendation of "Moderate Buy" from Brokerages
ProQR Therapeutics N.V. (NASDAQ:PRQR - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the nine analysts that are covering the company, MarketBeat.com reports. One...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
ProQR Therapeutics (NASDAQ:PRQR) Raised to Hold at Zacks Research
Zacks Research raised shares of ProQR Therapeutics from a "strong sell" rating to a "hold" rating in a research report on Thursday...
MarketBeat·27d ago
News Placeholder
ProQR Therapeutics (NASDAQ:PRQR) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS
ProQR Therapeutics (NASDAQ:PRQR - Get Free Report) posted its earnings results on Thursday. The biopharmaceutical company reported ($0.12) earnings per share for the quarter, missing analysts...
MarketBeat·1mo ago
News Placeholder
ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates
ProQR (PRQR) delivered earnings and revenue surprises of -20.00% and -60.57%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Alkermes (ALKS) Surpasses Q3 Earnings and Revenue Estimates
Alkermes (ALKS) delivered earnings and revenue surprises of +16.67% and +10.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates
Intellia Therapeutics (NTLA) delivered earnings and revenue surprises of +3.88% and +9.43%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest PRQR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.